For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The artificial pancreas is a technology in development to help people with diabetes automatically control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.
Scope of the Report:
This report focuses on the Artificial Pancreas Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In terms of application, diabetes type 1 is the biggest downstream consummer in the global artificial pancreas system in 2017, accounting for a more than 90% share. And the revenue form this segement is estimated to see a CAGR of 13.21% from 2017 to 2025.
The worldwide market for Artificial Pancreas Systems is expected to grow at a CAGR of roughly 10.8% over the next five years, will reach 170 million US$ in 2023, from 91 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Tandem Diabetes Care
- TypeZero Technologies
- Beta Bionics
- Johnson & Johnson
- Insulet Corp
- Bigfoot Biomedical
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Control to Range (CTR) System
- Control to Target (CTT) System
- Threshold Suspended Device
Market Segment by Applications, can be divided into
- Diabetes Type 1
- Diabetes Type 2
There are 15 Chapters to deeply display the global Artificial Pancreas Systems market.
Chapter 1, to describe Artificial Pancreas Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Artificial Pancreas Systems, with sales, revenue, and price of Artificial Pancreas Systems, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Artificial Pancreas Systems, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Artificial Pancreas Systems market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Artificial Pancreas Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source